People · Operator
Named in public records as an officer, director or promoter · active 2022–2022 · Biotechnology
| Company | Role | Sector | Stage | Raised · real | Value · est | Tied |
|---|---|---|---|---|---|---|
| Walking Fish Therapeutics, Inc. | — | Biotechnology | Series B | $41.5M | $250.7M | 2022 |
Daniel T. Janse at the center, the companies they're named on, and every other operator named alongside them — an interlock map of shared founding teams, boards and funds. Name-matched, so treat as a research lead.
People named alongside Daniel T. Janse on the same companies — an interlock signal (shared founding team, board, or fund). Name-matched, so verify before acting.
| Operator | Shared | Their companies |
|---|---|---|
| Lewis T. Williams | 1 | 5 |
| Franklin M. Berger | 1 | 4 |
| Momo M. Wu | 1 | 2 |
| Franklin T. Berger | 1 | 2 |
| Stella T. Xu | 1 | 1 |
| Momo T. Wu | 1 | 1 |
| Antonin De M. Fougerolles | 1 | 1 |
| Stella M. Xu | 1 | 1 |
| Alexis M. Ji | 1 | 1 |
| Alexis T. Ji | 1 | 1 |
| Antonin De T. Fougerolles | 1 | 1 |
| Manish T. Kothari | 1 | 1 |
People are matched by normalized name across records; a common name may merge distinct individuals. Treat as a research lead, the same way modeled valuations are directional, not quoted.